Professor Seeks FDA Probe Into Stem Cell Cos.' Practices

Law360, New York (March 14, 2012, 10:50 PM EDT) -- A University of Minnesota professor urged the U.S. Food and Drug Administration to investigate research firms CellTex Therapeutics Corp. and RNL Bio for their reported practices of treating patients including Texas Gov. Rick Perry with their own stem cells.

Professor Leigh Turner of U of M's Center for Bioethics asked the FDA to review a Feb. 10 draft rule approved by the Texas Medical Board to allow physicians in the state to use non-FDA approved stem cells, which Turner said was potentially lethal, to treat patients,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.